Objective: To evaluate the positive surgical margin rates and locations in radical prostatectomy among three surgical approaches, including open radical prostatectomy, laparoscopic radical prostatectomy and robot-assisted radical prostatectomy. Methods: We retrospectively reviewed clinical outcomes at our institution of 450 patients who received radical prostatectomy. Multiple surgeons were involved in the three approaches, and a single pathologist conducted the histopathological diagnoses. Positive surgical margin rates and locations among the three approaches were statistically assessed, and the risk factors of positive surgical margin were analyzed. Results: This study included 127, 136 and 187 patients in the open radical prostatectomy, laparoscopic radical prostatectomy and robot-assisted radical prostatectomy groups, respectively. The positive surgical margin rates were 27.6% (open radical prostatectomy), 18.4% (laparoscopic radical prostatectomy) and 13.4% (robot-assisted radical prostatectomy). In propensity score-matched analyses, the positive surgical margin rate in the robot-assisted radical prostatectomy was significantly lower than that in the open radical prostatectomy, whereas there was no significant difference in the positive surgical margin rates between robot-assisted radical prostatectomy and laparoscopic radical prostatectomy. In the multivariable analysis, PSA level at diagnosis and surgical approach (open radical prostatectomy vs robot-assisted radical prostatectomy) were independent risk factors for positive surgical margin. The apex was the most common location of positive surgical margin in the open radical prostatectomy and laparoscopic radical prostatectomy groups, whereas the bladder neck was the most common location in the robot-assisted radical prostatectomy group. The significant difference of positive surgical margin locations continued after the propensity score adjustment. Conclusions: Robot-assisted radical prostatectomy may potentially achieve the lowest positive surgical margin rate among three surgical approaches. The bladder neck was the most common © The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Introduction
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading cause of cancer-related deaths in men worldwide (1) . Radical prostatectomy (RP) is a gold standard treatment for clinically localized PCa (2) and has progressed in its surgical approach from open radical prostatectomy (ORP) to minimally invasive techniques, including laparoscopic RP (LRP) and robotassisted laparoscopic RP (RARP) (3) (4) (5) . A positive surgical margin (PSM) in RP is known to be associated with higher rates of biochemical recurrence (BCR) and cancer progression (6) (7) (8) (9) .
Several studies have investigated the outcomes of PSM rates and locations in different surgical RP approaches (8, 10) . However, the outcomes differ among the reports, and the superiority of minimally invasive approaches remains controversial. The largest series assessing the PSM rate in different RP surgical approaches demonstrated that the minimally invasive approach had a lower PSM rate than ORP (11) , whereas the PSM rate was the highest in RARP compared with that in ORP and LRP (12) . The reasons for these discrepancies are unclear; however, factors such as surgical approaches, surgeon/ center experience and the quality and technique of pathological diagnosis affect the results (11, 13) .
Previous studies found no difference in PSM locations among the different surgical approaches, and the most common location in all approaches was the apex. To the best of our knowledge, there were no studies that compared the PSM locations among different approaches using a propensity score-matched analysis. Here, we investigated the difference in PSM rates and locations after RP among three surgical approaches (ORP, LRP and RARP), which were performed by multiple surgeons at a single academic institution by adjusting multiple preclinical factors using a propensity scorematched analyses.
Patients and methods
We retrospectively reviewed the records of 589 patients who underwent RP at Akita University Hospital (Akita, Japan) between April 2004 and May 2016. Further analyses were conducted among 450 patients without any neoadjuvant therapy or with neoadjuvant hormonal therapy for <3 m. The study was approved by the Institutional Review Board, and a participant website with additional information, including an 'opt-out' button, was set up. Baseline characteristics such as age and PSA level at diagnosis, biopsy Gleason score, clinical T stage, risk subgroups, pathological Gleason score, pathological T stage and introduction of nervesparing technique were obtained from medical records. The three risk subgroups (low, intermediate or high) in localized PCa were defined based on a previous study by D'Amico et al. (14) . The approaches of ORP and LRP were previously described (15) , whereas RARP was mostly conducted by a transperitoneal posterior approach using the da Vinci S Robotic System (Intuitive Surgical, Sunnyvale, CA, USA). ORPs and LRPs were performed between 2004 and 2015, whereas the RARP was introduced in December 2012; the number of patients who underwent RARP after introduction annually increased. ORPs, LRPs and RARPs were performed by more than 20, 7 and 8 trained urologists, respectively. The introduction of unilateral or bilateral nerve sparing was determined based on patient preference, preoperative erectile function and oncological parameters, including positive regions on prostate biopsy and radiographic findings by magnetic resonance imaging (MRI).
RP specimens were inked with black and placed in formalin before processing. The specimens were sagittally sectioned in both apex and bladder neck, and the sections were pathologically evaluated according to the General Rule for Clinical and Pathological studies on PCa, as recommended by the Japanese Urological Association, Japanese Society of Pathology and Japan Radiological Society (16) . PSM was defined as a tumor that extended to the inked surface of the resected specimen, and the incidence and location of PSMs were determined according to a previous study (17) . A single pathologist conducted all histopathological diagnoses and prepared prostate specimens using the same method during the study period.
Statistical differences among the three groups were compared using the chi-squared test for categorical variables and KruskalWallis test for continuous variables. Independent preoperative risk factors were identified by univariate and multivariable analyses (i.e. age and PSA level at diagnosis, biopsy Gleason score, clinical T stage, nerve-sparing status, and surgical procedure). To balance the baseline characteristics and reduce the effect of confounders, we used a propensity score-matched analysis. The propensity scores were calculated for each patient using a multivariable logistic regression according to the following covariates: age and PSA level at diagnosis, biopsy Gleason score and clinical T stage. A 1:1:1 match was applied using a 0.05 caliper width. The differences in PSM rates and locations among the three RP approaches after propensity score adjustment were statistically assessed. All statistical analyses were performed using SPSS 22 statistical software (IBM Corp., NY, USA). All reported P values were two-sided with statistical significance at P < 0.05.
Results

Clinical characteristics
The patient characteristics are shown in Table 1 . The study included 127 (28.2%), 136 (30.2%) and 187 (41.6%) patients in the ORP, LRP and RARP groups, respectively. Statistically significant differences were found among the three groups in age at diagnosis (P = 0.001), PSA level at diagnosis (P < 0.001), biopsy Gleason score (P < 0.001), clinical T stage (P < 0.001), pathological Gleason score (P < 0.001), pathological T stage (P = 0.001) and introduction of nerve-sparing technique (P < 0.001). The median preoperative PSA level was highest in the ORP group (7.8 ng/ml in ORP, 6.8 ng/ml in LRP and 6.1 ng/ml in RARP), which also had the highest rate of D'Amico high-risk PCa (25.4% in ORP, 14.5% in LRP and 21.9% in RARP). These results suggested that ORPs tended to be performed in higher risk patients, and the clinical characteristics among the three groups varied in a crude database. To minimize confounding factors, the propensity score-matched analyses were performed to compare the impact of the surgical approaches on PSM rates and locations in all 100 patients. The characteristics after the adjustment are shown in Table 1 . The preoperative patient characteristics were well balanced after the score adjustment.
The rate of PSM
The unadjusted data showed that the crude PSM rates were 27.6% (35/127), 18.4% (25/136) and 13.4% (25/187) in the ORP, LRP and RARP groups, respectively. In subgroups with ≤pT2, the crude PSM rates were 9.7% or 16/165 (RARP), 15.0% or 16/107 (LRP) and 18.0% or 16/89 (ORP). Table 2 shows the logistic regression comparisons of PSM rates among the three groups. In the propensity score-matched analysis, the PSM rates were 27.0% (ORP), 22.0% (LRP) and 15.0% (RARP) ( Table 1 ). In the subgroups with ≤pT2, the PSM rates were 17.3% (ORP), 17 .1% (LRP) and 10.3% (RARP). In all patients, the odds ratio (OR) of PSM in the RARP group was significantly lower than that in the ORP group (OR = 0.477; range, 0.236-0.965; P = 0.040), whereas there was no significant difference in the PSM rates between the RARP and LRP groups (OR = 0.626; range, 0.303-1.291; P = 0.205). Regarding the patients with ≤pT2, there were no significant differences in PSM rates among the three groups (Table 2) ; however, the PSM rate was the lowest in the RARP group.
Preoperative risk factors for PSM
To assess the preoperative risk factors for PSM after the propensity score adjustment, the univariate and multivariable logistic regression analyses were performed (Table 3 ). In the univariate analysis, the PSA level at diagnosis (OR = 1.093; range, 1.020-1.172; P = 0.012) and RARP (OR = 0.477; range, 0.236-0.965, P = 0.040) were associated with a risk of PSM. In the multivariable analysis, the PSA level at diagnosis (OR = 1.102; range, 1.020-1.172; P = 0.014) and Table 1 . Patient characteristics before and after propensity score matching Before propensity score matching After propensity score matching ORP (n = 127) LRP (n = 136) RARP (n = 187) P value ORP (n = 100) LRP (n = 100) RARP (n = 100) P value not RARP (OR = 0.477; range, 0.199-0.863; P = 0.019) were independent risk factors for PSM.
Location of PSM
Furthermore, we assessed the relationship between the PSM locations and selected surgical approaches after performing propensity score matching (Table 4 ). The most common site of PSMs in the ORP (44.4%) and LRP (59.1%) groups was the apex, whereas in the RARP group, it was the bladder neck (40.0%). The PSM rate at the bladder neck was significantly different in the analysis after propensity score matching (P = 0.008). There was no difference in the PSM rates at the other locations among the three groups. These results suggested that RARP has a potential to have a different profile of PSM location; particularly, the PSM rate at the bladder neck was relatively higher than that in the other two groups.
Discussion
In the present study, we evaluated the PSM rates and locations using three RP approaches (ORP, LRP and RARP) at a single institution. Interestingly, multiple surgeons were involved in the surgeries and a single pathologist evaluated all pathological findings. The PSM rates in the RARP group were the lowest among the three RP approaches and continued to be lower than those in the ORP group after the propensity score-matched analysis. The number of patients who underwent RARP is rapidly increasing; however, not a few numbers of LRP and ORP have been still performed in Japan. Furthermore, the cost-benefit balance is still an obstacle to its widespread (18) . In this study, we demonstrated an advantage of RARP from the perspective of low PSM rate in comparison with other RP procedures. Furthermore, the PSM locations in the RARP group were different than those in the other two approaches, and the PSM rate at the 
bladder neck in the RARP group was higher than that in the other two groups.
Only a few studies comparing PSM characteristics among the three RP approaches performed at a single institution have been reported (12, 13) . A propensity score-matched analysis assessed pathological and biochemical outcomes among the approaches using 522 patients who underwent RP at two campuses of a single US institution and showed that the PSM rate in the RARP group was significantly higher than that in the other two groups (12) . However, the PSM rates in the RARP group were 19.5%, which is relatively higher than that calculated in the current study (13.4%), albeit no significant difference was noted in terms of the BCR rate among the three procedures. Another study investigated the trends in clinical outcomes in RARP in a UK regional tertiary center and demonstrated that the PSM rate decreased over a 10-year period (19) . We speculated that the PSM rates decreased after RARP development due to better educational systems and improved surgical technique. In fact, the largest multinational and multi-institutional study of 22 393 patients treated with RP showed that the PSM rate was 13.8% (RARP), 16.3% (LRP) and 22.8% (ORP). The PSM rate in the RARP group was quite comparable with our result, although the rates in the ORP and LRP groups were relatively lower than those in the current study. The study concluded that the risk of PSM in the LRP and RARP groups was lower than that in the ORP group after adjustment for various clinical risk factors (11) . Remarkably, a significant comparison of PSM rates among the studies was difficult due to differences in race, inclusion criteria, sample size, number of surgeons and surgical quality; however, our result was consistent with the previous study, indicating that minimally invasive techniques, particularly RARP, reduce the risk of a PSM compared with open surgery.
It remains controversial whether different RP approaches are associated with a specific PSM location (20) (21) (22) . A previous study showed that PSM locations in 93 patients after RP performed in the same year (37, 19 and 37 patients with ORP, LRP and RARP, respectively) at a single institution in the USA demonstrated that the apex/distal was the most common site of PSMs in all approaches (62% in ORP, 79% in LRP and 60% in RARP) (13) . In the current study, the profile of PSM locations was slightly different among the three RP approaches. Although there was no previous report emphasizing the risk of PSMs at the bladder neck, bladder neck transection in RARP can be problematic due to the junction's innate natural anatomic variability and the absence of obvious visual landmarks during transperitoneal and antegrade approaches (23) . Additionally, the bladder neck preservation during RP improved early recovery and overall 1-year urinary continence in a systematic review and its meta-analysis (24) . Our results suggested that the bladder neck dissection requires careful attention. Recently, several imaging techniques, including multi-parametric MRI (mpMRI), have been applied to patients who underwent RP. Lee et al. reported that non-organ-confined disease (as determined by mpMRI) was significantly associated with PSM and pathological T3 disease (25) . The careful preoperative imaging of the bladder neck by mpMRI and the usage of 30°down scope may be useful in avoiding PSM incidence in patients with advanced PCa, while balancing quality of life and the surgical curability index.
The baseline PSA level was an independent predictive factor for PSM (except for the difference in the surgical procedure) in the current study. In a series including 216 patients treated with RARP by one fellowship-trained urological oncologist, the only preoperative factors associated with a greater risk of PSMs were the PSA level (P = 0.012) and PSA density (P = 0.005). Additionally, a recent study that evaluated overall rate, location and predictive factors for PSM in 271 patients with high-risk PCa who underwent RARP in a single center (26) demonstrated that PSA levels and clinical stage were independent predictive factors for PSM. Including the current study, these results suggest that preoperative PSA levels and its related biomarkers were strong predictors of PSMs. Nerve sparing is one of the other potential risk factors of PSM (27, 28) . A metaanalysis of 124 studies to investigate the impact of nerve sparing on PSM rates during RP (29) showed that nerve sparing did not increase PSM risks in patients with pT2 [relative risk (RR) = 0.92, 95% confidence interval (CI) = 0.75-1.13] and pT3 disease (RR = 0.83, 95% CI = 0.71-0.96). Consistent with the meta-analysis, our study found that nerve sparing was not associated with PSM in the univariate and multivariable analyses. Although the results should be carefully interpreted because of the wide variation of nervesparing techniques and the presence of missing values, nerve sparing can be safely administered during RP. The relationship between nerve sparing and PSM location in clinical outcomes should be investigated in future studies.
The present study has several limitations. First, despite using propensity score-matched analyses to compare PSM status, we could not exclude the impact of residual confounding factors because the groups had different backgrounds. In fact, the PSM rates in the ORP and LRP groups were relatively high compared with those of previous studies. Only a randomized study can achieve a better matching among the three groups. Additionally, among the three groups, we did not assess the differences in terms of perioperative complications, functional outcomes, BCR rates, progression-free survival and overall survival rates, as this was not our primary goal.
In conclusion, RARP achieved the lowest PSM rates among the three RP approaches and decreased PSMs compared with ORP after propensity score adjustment. Additionally, it had a different profile of PSM locations with high rates of PSMs at the bladder neck. Thus, RARP may reduce the PSM rates, provided that dissection of the bladder neck is carefully conducted to avoid PSMs.
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